Aims: The present study was performed to evaluate Atrial Natriuretic Peptide (ANP) effects on intracellular pH, phospholipase D and ROS production and the possible relationship among them in HepG2 cells. Cancer extracellular microenvironment is more acidic than normal tissues and the activation of NHE-1, the only system able to regulate pHi homeostasis in this condition , can represent an important event in cell proliferation and malignant transformation. Methods: The ANP effects on pHi were evaluated by fluorescence spectrometry. The effects on p38 MAPK and ROS production were evaluated by immunoblots and analysis of DCF-DA fluorescence, respectively. RT-PCR analysis and Western blotting were used to determine the ANP effect on mRNA NHE-1 expression and protein levels. PLD-catalyzed conversion of phosphatidylcholine to phosphatydilethanol (PetOH), in the presence of ethanol, was monitored by thin layer chromatography. Results: A significant pHi decrease was observed in ANP-treated HepG2 cells and this effect was paralleled by the enhancement of PLD activity and ROS production. The ANP effect on pHi was coupled to an increased p38 MAPK phosphorylation and a down-regulation of mRNA NHE-1 expression and protein levels. Moreover, the relationship between PLD and ROS production was demonstrated by calphostin-c, a potent inhibitor of PLD. At the same time, all assessed ANP-effects were mediated by NPR-C receptors. Conclusion: Our results indicate that ANP recruits a signal pathway associated with p38 MAPK, NHE-1 and PLD responsible for ROS production, suggesting a possible role for ANP as novel modulator of ROS generation in HepG2 cells.
Introduction
Atrial Natriuretic Peptide (ANP), a cardiovascular hormone mainly secreted by heart atria in response to mechanical stress, besides inducing natriuresis and vasodilation in vivo [1, 2] , also acts as autocrine/paracrine 78 factor [3] in different organs, such as kidney, lung, thymus and liver [4] [5] [6] [7] , under physiological as well as pathophysiologic conditions (e. g., cancer) [8] . ANP promotes its biological effects by interacting with two major types of receptors located on plasma membranes of target cells: NPR-A receptors, which activate the guanylate cyclase (GC)/cGMP system, and NPR-C receptors, which inhibit the adenylate cyclase (AC)/cAMP system [9] or the membrane lipid turnover through the activation of specific phospholipases [10] . Among different biological effects, in hepatoblastoma (HepG2) cells, ANP inhibits cell proliferation through the selective upregulation of the expression of the NPR-C receptors associated with decreased intracellular concentrations of cAMP [11] . Furthermore, ANP can inhibit or stimulate Na + /H + exchanger isoform 1 (NHE-1) depending on cell type [12, 13] .
In cancerous tissues, extracellular microenvironment is more acid than in normal tissues [14] and the NHE-1, a plasma membrane protein that exchanges Na + and H + ions according to their concentration gradients [15] , concurs to minimize changes in intracellular pH (pHi) and to maintain tumour cell viability. Signal transduction leading to NHE-1 modulation can involve several mitogenactivated protein (MAP) kinases, including p38 MAP kinase [16] . MAP kinases represent an important component of the intracellular signal transduction cascade and regulate a wide range of cell processes including gene transcription, cytoskeletal organization, cell growth and ion homeostasis [17] .
Previous reports [18, 19] have suggested that ANP plays a dual role on p38 MAP kinases, inhibiting or stimulating the enzyme activity depending on cell types. In addition, pHi changes in response to a variety of biologically active molecules may act as signaling events regulating different downstream effectors including phospholipase D (PLD) [20] , the latter being also activated by ANP at early and long times [21, 22] . PLD catalyzes the hydrolysis of the terminal diester bond of phosphatidylcholine to liberate phosphatidic acid (PA) and choline [23] . A role for PA as key intracellular signaling molecule activating protein kinases, phospholipases and protein tyrosin kinases, has been proposed [24] . Moreover, PA also promotes Reactive Oxygen Species (ROS) production through the NADPH oxidase involvement [25] , which, in turn, appears to play a role as cell death mediator in HepG2 cells [26] .
Taken together, previous findings suggest a possible relationship among ANP-induced pHi modulation, PLD activation and related downstream signalling systems, such as ROS production. Therefore, the aim of the present study was: (i) to assess the effect of ANP on pHi through the involvement of NHE-1; (ii) to define the role of p38 MAP kinases in ANP-induced pHi modulation; (iii) to establish whether NHE-1 may be responsible for PLD modulation and ROS production in HepG2 cells. The in vitro model was selected because, HepG2 cells are highly sensitive to ANP [11] and the NHE-1 exchanger is more active than in normal hepatocytes [27, 28] .
Materials and Methods
RPMI 1640, trypsin, glutamine, penicillin (10,000 UI/ml), streptomycin (10,000 µg/ml) and sodium pyruvate were from Eurobio Laboratoires (Le Ulis Cedex, France). Foetal Calf Serum (FCS) was from GIBCO (Grand Island, NY). ANP, ethylenediaminetetraacetic acid tetrasodium salt dehydrate (EDTA), Sodium Dodecyl Sulphate (SDS), Phosphate Buffer Saline (PBS), Triton X100, Dithiotreitol, Mercaptoethanol, Glycerol, Sodium Vanadate, Dimethyl Sulfoxide (DMSO), Pepstatin, Aprotenin, Leupetin, Tris-HCl, Bromophenol blue, Phenylmethylsulfonylfluoride (PMFS), N-2-hydorxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), Ethidium bromide, 8-Br-cGMP, cANF, calphostin-c, monensin, Trypan blue, 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), (3-m e t h y l s u l p h o n y l -4 -p i p e r -i d i n o b e n z o y l ) g u a n i d i n e methanesulphonate) (Hoe-694) were from Sigma Chemicals (St. Louis, MO). 2',7'-dichlorofluorescein diacetate (DCF-DA) and 2'-7' -bis(carboxyethyl)-5(6)-carboxy-fluorescein (BCECF/AM) were from Molecular Probes, Inc. (Eugene, OR). SB203580 and SB202474 were from Calbiochem. Antiphospho-and total p38 kinase and anti sodium-hydrogen exchanger (NHE-1) antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase-conjugated secondary antibody and chemiluminescence detection of immunoreactive bands ECL reagents were from Pierce (Rockford, IL). RnaseH, human (NHE-1) primers were from Invitrogen. Taq DNA polymerase, Dnase, (α- 
Cell Culture
Hepatoblastoma (HepG2) cell line was purchased from American Type Culture Collection (ATCC, Rockville, MA) and cultured in RPMI-1640 medium supplemented with 10% Foetal Calf Serum (FCS), 4 mM glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin and 100 µg/ml streptomycin. Cells were maintained in a humidified incubator at 37 °C in a 5% CO 2 atmosphere. HepG2 cells, harvested once a week by 0.25% trypsin 0.02% EDTA and re-fed every other day, were used at about 80% confluence after 4-6 days at passage level 4-10. HepG2 cells were grown in 35 mm dishes and serum starved for 24 h before each experiment to rule out possible interferences with cell growth due to serum components and to promote their synchronization. Cells were adapted to HEPES or Krebs buffer for at least 5 hours before each experiment.
pH measurement Intracellular pH (pHi) was measured by fluorescence spectrometry using the intracellular probe 2'-7'-bis (carboxyethyl)-5(6)-carboxyfluorescein (BCECF/AM), as previously described [29] Incubation with the fluorescent dye was carried out as follows: cells were washed twice and incubated in either HEPES or Krebs buffer with 1mg/ml fluorescent dye in dimethylsulfoxide (DMSO) at the final concentration of 1µg/ml for 30 min at 37°C in the dark. After incubation, the medium containing the dye was discarded and cells were washed twice with the same buffer. The calibration curve was carried out as previously reported [30] using the nigericin method in high potassium medium with the same composition as the HEPES buffer, but with NaCl substituted by equimolar KCl. The calibration curve was linear in the pH range 6.5-7.5 (not shown). Fluorescence was measured under continuous magnetic stirring at controlled temperature (37°C) in a Perkin-Elmer LS-5 luminescence spectrometer equipped with a chart recorder model R 100A, with excitation and emission wavelengths of 500 nm and 530 nm, using 5 and 10 nm slits, respectively for the two light paths. Fluorescence was also routinely measured at 450 nm excitation (at this wavelength, the fluorescence is proportional to intracellular dye concentration, but is relatively pH insensitive) and the value did not change more than 10% during the experimental period. NHE-1 blocking was obtained with the specific inhibitors 5-(Nethyl-N-isopropyl)amiloride (EIPA) and (3-methylsulphonyl-4-piper-idinobenzoyl)guanidine methanesulphonate) (Hoe-694) and cell mortality was evaluated by Trypan blue staining using a Neubauer modified chamber. When requested, monensin was used at 10µM final concentration.
Immunoblots
Cells, grown in 6-well plates (10 5 cells/well), were synchronized as reported above and incubated in 2 ml RPMI 1640 without FCS, in the presence or absence of 10 -10 M ANP for different experimental times. After washing with PBS, cells were centrifuged at 1,500 rpm at 4°C for 5 min and the pellet was lysed with sample buffer containing: 10% sodium dodecyl sulfate (SDS), 10% glycerol, 100 mM dithiotreitol, 5% β-mercaptoetanol, 1% bromophenol blue, 2mM EDTA, 1 mM sodium vanadate, 50 mM Tris-HCl (pH 6.8), plus a cocktail of protease inhibitors (1 mM phenylmethylsulfonylfluoride, 1µg/ ml pepstatin, 10 µg/ml leupeptin, 10 µg/ml aprotenin). The lysate was centrifuged at 13,000 rpm for 5 min; the supernatant was boiled for two minutes and then stored at -70°C. The protein content of cell lysates was assessed by the method of Lowry et al. [31] . Equal amounts of whole cell lysate (30-50 ìg) were subjected to 8% (p38 MAPK) and 10% (NHE-1) acrylamide SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with primary anti-phosphorylated and total p38 MAP kinase antibodies (both 1:1000) overnight at 4°C or with the primary rabbit polyclonal antibodies for NHE-1 (1:100). A horseradish, peroxidase-conjugated secondary antibodies (1:2500) was used for 1 hour at room temperature. Membranes were counterblotted with 1:5000 dilution of monoclonal anti-β-actin antibodies (Sigma) to ensure same amounts of protein loading on the membranes. Membranes were analyzed by ECL and each experiment was repeated at least three times.
RNA extraction and RT-PCR analysis
Total RNA was extracted from HepG2 cells (about 5 x 10 6 ) using the single-step method of extraction described by Chomczynski and Sacchi [32] . RNA concentration was determined spectrometrically with a BioPhotometer (Eppendorf, Hamburg, Germany), measuring UV absorbance at 260 nm; the integrity of RNA preparations was assessed by electrophoresis on agarose gel. Total RNA (1 µg) was DNase treated (Amersham Pharmacia Biotech) and reverse-transcribed into cDNA by the random hexanucleotide technique using 100 U of Moloney murine leukemia virus reverse transcriptase (RNaseH) and random primers p(dN) 6 (Roche) as previously described [22] . For the RT-PCR analysis, an equal amount (10 pg) of an internal control RNA was added to each sample before reverse transcription. This RNA was obtained by in vitro transcription (Ambion, Austin, TX) of the Xenopus ribosomal protein L22 sequence (a. n.: X64207) and detected with specific oligonucleotides. An aliquot of RT reaction (2 µl) was PCRamplified in a final volume of 50 µl by using 200 µM concentration of dATP, dGTP, dTTP and 10 µM of dCTP, 0.5 U of Taq DNA polymerase (Amersham Pharmacia Biotech), 0.2 µCi (α-32 P)dCTP (Amersham Pharmacia Biotech; 3000 Ci/mmol) and 20 pmol of each primer designed to amplify the Na/H exchanger1 (NHE1) mRNA coding sequence. The following primes were used based upon the sequence for the human NHE1 mRNA sequence (ID: AF141359); upstream 5'-CCT TCT GAC AGG CAT CGA AG-3', downstream 5'-CCG TCA GGT AGT TGT TGA TCT-3' (fragment size: 470 bp). To normalize the experiments, besides L22 cDNA, the housekeeping cDNA of human β-actin (ID: NM001101) was amplified with the following oligonucleotides: upstream 5'-GCA CTC TTC CAG CCT TCC-3', downstream 5'-GCG CTC AGG AGG AGG AAT-3' (fragment size: 193 bp). All transcripts were amplified as follows: 94°C foreach PCR reaction to avoid saturation (25 cycles for NHE1 and L22 cDNAs and 15 cycles for β-actin cDNA). The amplified fragments were separated on 5% polyacrylamide gel and quantified by the phosphoimager (Molecular Dynamics). M calphostin-c, potent direct and irreversible inhibitor of PLD isoenzyme catalytic domain [33] , or 5µM SB203580, inhibitor of p38 MAPK [34] . Incubation was stopped with 1 ml of ice-cold methanol. Cells (1x10 6 ) were scraped off and lipids were extracted by the method of Bligh and Dyer [35] . Dried lipids were redissolved in 20 µl of CH 3 Cl. Since the PA produced is rapidly metabolized and could arise from other sources, we measured the formation of PetOH, a widely accepted direct measure of PLD activity [36] . Phosphatidylethanol (PetOH) was separated by thin-layer chromatography on 10x20 cm silica gel 60 plates. The solvent system consisted of ethyl acetate/isooctane/acetic acid/H 2 O (130/20/30/100, v/v). After chromatography, plates were dried under N 2 and spots revealed under iodine vapor were scraped off, eluted with 0.2 ml ethanol and counted for radioactivity after the addition of 7 ml Optifluor (Packard Instruments, Downers Grove, IL). PetOH was identified by comparing its Rf value with a standard, according to Chattopadhyay [37] .
Thin layer chromatography of lipids and transphosphadylation reaction

Detection of ROS in HepG2 cells
Dichlorofluorescein Diacetate (DCF-DA) was dissolved in DMSO at the concentration of 1 mM and kept at -20 °C in the dark; it was freshly diluted before each experiment. Cells (1x10 6 ) were synchronized as reported above, resuspended in PBS buffer and loaded with the fluorescent indicator DCF-DA at the final concentration of 10 µM for 60 min at 37°C in the dark [38] . After the incubation with the fluorescent dye, HepG2 cells were washed twice with PBS buffer, centrifuged for 5 min at 1.500 rpm at room temperature, resuspended in PBS and challenged with ANP; in other experiments, cells were pretreated with different effectors for 1h at 37°C in the dark. A sample of 1x10 5 cells was used to monitor ROS production. Fluorescence was measured under continuous magnetic stirring and controlled temperature (37°C) in a Perkin-Elmer luminescence spectrometer (model LS-5) equipped with a chart recorder (model R 100A), with excitation wavelength at 485 nm and emission wavelength at 530 nm using 5 and 10 nm slits for each light path, respectively,. Results are expressed as Fluorescence Intensity, reported as Fluorescence Units (F.U.), of cells loaded with only DCF-DA (Control) or also treated with 300 µM H 2 O 2 for 1h as positive control.
Statistical analysis
Data distribution was preliminarily verified by the Kolmogorov -Smirnov test. Each experimental set was independently performed and compared with the same control by Student's t-test. The study was not aimed at investigating the potential variability among different experimental sets. Quantitative data are expressed as the mean ± SD of at least four replicate determinations. Differences were regarded as significant when P value was less than 0.5. M; (ii) in Krebs buffer, the average pHi at rest was 7.07±0.1 and no significant ANP effects were observed with respect to control values (Fig.1, inset) .
Results
Intracellular acidification in HepG2 cells
In Fig.2 , the time-course of pHi in the presence of 10 -10 M ANP is shown. The ANP effect was already significant after 4 hours treatment, while no significant differences were present between 4and 6 hours treatment. For this reason, 10 -10 M ANP for 6 hours was used in all subsequent experiments.
To further verify whether NHE-1 was involved in ANP-induced pHi decrease, we carried out experiments in HEPES buffer in the presence of 1µM EIPA or 3 µM Hoe-694, specific inhibitors of the exchanger. Fig.3a shows that ANP has the similar acidifying effect as EIPA or Hoe-694, while ANP plus EIPA or ANP plus Hoe-694 has not additive effects. Fig.3b shows that 10 µM monensin, a Na + ionophore capable to collapse Na + and H + gradients [39] , induces a significant pHi increase with respect to untreated cells, while monensin plus ANP inhibits the hormone effect on pHi. Taken together, these results suggest a possible involvement of NHE-1 in ANPinduced pHi decrease in HepG2 cells.
Since p38 MAPK plays a key role in the modulation of NHE-1 [16, 40], we evaluated (i) the ability of ANP to phosphorylate such kinase and (ii) the possible role of this enzyme in ANP-induced pHi decrease. Immunoblots showed that p38 MAPK was constitutively activated and a time-dependent increase was detected after exposure to ANP with respect to untreated cells, with a maximal activation after 6 hours (Fig.4) . The involvement of p38 MAPK in ANP-dependent pHi decrease was investigated in the presence of either 5µM SB203580, a specific inhibitor of the enzyme, or 10µM SB202474, an inactive analogue, as a control. Our results showed that the pHi decrease was entirely reverted only in the presence of SB203580 (Fig.5) , confirming the involvement of this kinase in the mechanism through which ANP induced pHi decrease in HepG2 cells.
To investigate whether the marked ANP effects on pHi was due to a decreased NHE-1 expression, we performed time-course experiments on mRNA NHE-1 expression and protein levels in HepG2 cells treated or not with ANP (Fig. 6a,b,c) . ANP significantly decreased mRNA NHE-1 expression already at 4 hours, while no significant differences were present between 4 and 6 hours treatment; these effects were totally inhibited in the presence of 5µM SB203580 (Fig.6 a,b) . In addition, ANP was also able to decrease protein levels of NHE-1 (Fig. 6c) . Such an effect was counteracted by SB203580, suggesting a key role of this enzyme in the down-regulation of ANP-induced NHE-1 expression.
Phosphatidylethanol (PetOH) production after intracellular acidification
Changes in pHi observed in response to an array of ligands may be considered signaling events for the activation of downstream effectors including phospholipases [20] . We investigated a possible relationship between pHi and phospholipase D (PLD) activity by the transphosphatidylation reaction, which catalyses, in the presence of ethanol, the phosphatidylethanol (PetOH) formation [36] . In Fig.7a significant time-dependent increase in PetOH production after 4 hours treatment, while no significant differences were present between 4 and 6 hours; (ii) no significant ANP-induced PetOH increase was obtained in Krebs buffer (Fig.7a) as well as in HEPES buffer after adding monensin (data not shown). Changes in the concentration of short-chain primary alcohols, such as ethanol, represent a method to inhibit PLD-mediated production of PetOH by the transphosphatidylation reaction [36] . In Fig. 7a , inset, we report the dose-response curve of PetOH production in HepG2 cells incubated with different ethanol concentrations (0.03-1% v/v) before the exposition to ANP a b for 6 hours. In this regard, we observed a significant ethanol concentration-dependent increase in PetOH production after ANP stimulation, suggesting that PLD may represent a downstream target for the hormone. Since ethanol can modify pHi in hepatocytes [41] , we monitored ANP effects on pHi in the presence of different ethanol concentrations and no significant differences were observed (data not shown). Therefore, we carried out experiments to evaluate PetOH production after ANP exposure in the presence of 10 M calphostin-c or 5µM SB203580 alone were uneffective, while a total inhibition of the ANP effect was observed after pretreatment with SB203580 as well as calphostin-c. Fig. 7b , inset, shows that EIPA was able to mimic ANP effects on PetOH production and no additive effects were present with ANP plus EIPA. Experiments carried out in Krebs buffer showed no significant ANP effects on PetOH production (data not shown), suggesting a possible relationship between ANPinduced intracellular acidification and PLD activity in HepG2 cells.
PLD activity and Reactive Oxygen Species (ROS) production
Since PA enhances ROS production in several cell types [42] , we examined the interplay between ANPinduced PLD activation and ROS production in HepG2 cells. In Fig.8, inset a, time-dependent increase in ROS production after 4 hours treatment, while no significant differences were present between 4 and 6 hours. Experiments carried out in the presence or absence of calphostin-c in HepG2 cells after 6 hours stimulation with ANP in HEPES buffer showed that (Fig.8 ): (i) ANP induced a significant increase in ROS production with respect to untreated cells; (ii) calphostin c alone did not affect ROS production, while the pretreatment with the inhibitor totally abrogated ANP-induced ROS production; (iii) similar results were obtained in the presence of SB203580. Finally, Fig. 8, inset b, shows that EIPA was able to mimic ANP effects on ROS production and no additive effects were present with ANP plus EIPA. Taken together, these results suggest a possible link among ANPinduced intracellular acidification, phospholipase D activation and ROS production with the involvement of p38 MAP kinase.
Selectivity of ANP receptors in HepG2 cells
The potential role of ANP-receptors in the above reported hormone-induced effects was investigated. We carried out experiments with 8-Br-cGMP, a non hydrolysable analogue of cGMP involved in ANP effects mediated by NPR-A receptors, and cANF (4-23), the ring-deleted analogue of ANP acting as specific activator of NPR-C receptors. Fig. 9 shows that 10 -10 M cANF was able to mimic ANP-induced effects on pHi (a), PLD activation (b) and ROS production (c), while 50 µM 8-Br-cGMP was ineffective, suggesting the involvement of NPR-C receptors in the hormone action.
Discussion
Cellular ionic events, such as changes in transmembrane electric potential, Na + and Ca ++ intracellular concentrations and intracellular pH, are necessary to regulate cell functions. Several transport systems are involved in pHi homeostasis. One of the best described is NHE-1, a plasma membrane protein, which plays a regulative role being activated by hormones and growth factors [15] . In several tumors, the extracellular microenvironment is more acidic than normal tissues; in these conditions, the NHE-1 exchanger represents the only system able to regulate pHi homeostasis. The early activation of NHE-1 is also considered as an important event in cell proliferation and malignant transformation [43] . Conversely, ANP contributes to cell growth modulation by eliciting an antiproliferative action in different cell types. In hepatocellular carcinoma and HepG2 cells, an increased expression of ANP can decrease cell growth by NPR-C downregulation [11] and NHE-1 mRNA levels and the exchanger activity are 10 and 3 fold higher than in normal hepatocytes, respectively [27, 28] . These features prompted us to consider this cell type to investigate on possible effects of ANP on intracellular acidification. Our results show that, in HepG2 cells, ANP effects on pHi were present only at peptide concentrations as low as 10 -10 M, i. e. within the physiological range of ANP plasma concentrations, the missed response to higher concentrations being determined by a possible NPR-A receptor downregulation due to long-term effects of ANP [44] , as already suggested in human macrophages [22] . Remarkably, these results were obtained in HEPES buffer to more closely mimic the acidic environmental conditions typical of malignant cells, in which NHE-1, represents the only system involved in pHi homeostasis [43] .
ANP can early regulate pHi through NHE-1 [12, 13, 34] . In fact, pharmacological concentrations of the hormone inhibit NHE-1 by a mechanism that includes increased intracellular levels of cGMP, while physiological concentrations can stimulate NHE-1 through the diacylglycerol production or cAMP decrease [13] . Kusuhara et al. [16] showed that p38 MAPK is able to induce an early decrease NHE-1 activity proposing two possible mechanisms. First, p38 MAPK may phosphorylate NHE-1, causing a conformational change that inhibits the transport activity; second, the kinase may decrease the p42/44 MAPK activity responsible for the inhibition of downstream effectors, such as NHE-1 kinases. Our observations show that the ANP-induced pHi decrease in HepG2 cells involves the phosphorylation of p38 MAPK leading to the downregulation of NHE-1 mRNA and protein levels, suggesting a key role for p38 MAPK as upstream effectors for ANP signaling pathways.
Changes in pHi induced by a variety of biologically active molecules, such as ANP, may act as signaling event for the regulation of downstream effectors including phospholipase D [20, 22] . In this respect, in HepG2 cells, ANP induces a significant increase in PetOH intracellular levels through PLD activation, as also confirmed by the treatment with calphostin-c, a potent inhibitor of the enzyme [33] . Since PLD activation can be enhanced when NHE-1 is inhibited [20] , experiments were carried out in the presence of EIPA, to inhibit NHE-1 exchanger: the inhibitor was able to mimic ANP effects on PLD activity, suggesting interplay between pHi and ANP-muscle cells.
Am induced PLD activation. Moreover, the hormone effects on pHi and PLD activation were also inhibited by SB203580, an inhibitor of p38 MAPK, confirming a significant role of this kinase as downstream effector of ANP signaling pathways.
In HepG2 cells [26, 45] , different agonists can induce ROS production which can play a role as mediator of cell death. Here, we show that changes in pHi exhibited in response to physiological concentrations of ANP can be responsible for ROS production through the activation of p38 MAPK and PLD. Since experimental evidences [46] describe the ability of ANP to inhibit cell growth, our data support the possibility that ROS production may be involved in the mechanism by which ANP inhibits HepG2 cell growth, by necrosis [47] Finally, our findings appear partially in disagreement with previous reports showing the ANP ability to reduce liver ischemia/reperfusion injury and improving hepatocytes resistance to oxidative stress [48] . It should not be surprising that ANP elicits different effects. In fact, hormone effects can be determined through different pathways depending on the phenotypic state of cells [49] . In particular, cells which undergo phenotypic modulation express a relatively high number of NPR-C receptors and are highly sensitive to ANP [49] . In hepatoblastoma cells, the ability of ANP to inhibit proliferation has been attributed to the selective upregulation of C-ANP receptor expression [11] . Since all biological effects assessed in this study were due to physiological concentrations of ANP and, at the same time, NHE-1 inhibition was related to cell proliferation, we speculate that the NPR-C receptor upregulation can be involved in ANP effects on HepG2 cells. Interestingly, our results show that cANF, the NPR-C specific ring deleted analogue of ANP, is able to mimic ANP-induced effects on pHi, PLD activity and ROS production demonstrating, for the first time, an important role for NPR-C receptors in ANP-induced ROS production.
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